A drug repurposing screen identifies altiratinib as a selective inhibitor of a key regulatory splicing kinase and a potential therapeutic for toxoplasmosis and malaria
Christopher Swale(Inserm), Mohamed‐Ali Hakimi(Centre National de la Recherche Scientifique)
Cited by 1
Related Papers
<i>Toxoplasma</i>Effectors Targeting Host Signaling and Transcription
|Clinical Microbiology Reviews|2017|349
A <i>Toxoplasma</i> dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation
|The Journal of Experimental Medicine|2013|283
A MORC-driven transcriptional switch controls Toxoplasma developmental trajectories and sexual commitment
|Nature Microbiology|2020|137